Fmr LLC Acquires 1,095,805 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

FMR LLC raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 97.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,218,112 shares of the medical device company's stock after buying an additional 1,095,805 shares during the period. FMR LLC owned about 1.11% of Cooper Companies worth $203,911,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Fulton Bank N.A. raised its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Torray Investment Partners LLC increased its position in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after purchasing an additional 132 shares during the period. Mather Group LLC. raised its holdings in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after purchasing an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after purchasing an additional 136 shares in the last quarter. Finally, Greenleaf Trust lifted its position in shares of Cooper Companies by 5.0% in the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock worth $268,000 after purchasing an additional 139 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on COO shares. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Robert W. Baird reduced their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Finally, BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Stock Down 1.2 %

NASDAQ:COO traded down $0.96 during trading hours on Tuesday, reaching $77.80. 1,386,329 shares of the company traded hands, compared to its average volume of 1,399,687. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The stock has a market capitalization of $15.56 billion, a P/E ratio of 39.90, a P/E/G ratio of 2.25 and a beta of 1.01. The business's 50-day moving average price is $83.93 and its two-hundred day moving average price is $94.19. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.